| Product Code: ETC9978340 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States experienced a significant shift in transdermal drug delivery import shipments in 2024, with top exporting countries including Israel, Belgium, Japan, Sweden, and Denmark. The market concentration, as measured by the HHI, decreased from moderate to low concentration within a year, indicating a more diversified import landscape. The compound annual growth rate (CAGR) from 2020 to 2024 stood at a steady 4.49%, with a notable growth rate of 7.75% from 2023 to 2024, reflecting a promising trajectory for the transdermal drug delivery systems market in the US.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Transdermal Drug Delivery Systems Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, 2022 & 2032F |
3.3 United States (US) Transdermal Drug Delivery Systems Market - Industry Life Cycle |
3.4 United States (US) Transdermal Drug Delivery Systems Market - Porter's Five Forces |
3.5 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume Share, By Application, 2022 & 2032F |
4 United States (US) Transdermal Drug Delivery Systems Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases requiring long-term medication |
4.2.2 Growing geriatric population in the United States |
4.2.3 Convenience and ease of use offered by transdermal drug delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of transdermal drug delivery systems |
4.3.2 Potential skin irritations or allergic reactions associated with transdermal patches |
4.3.3 Limited drug molecules that can effectively penetrate the skin barrier |
5 United States (US) Transdermal Drug Delivery Systems Market Trends |
6 United States (US) Transdermal Drug Delivery Systems Market, By Types |
6.1 United States (US) Transdermal Drug Delivery Systems Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Electroporation, 2022 - 2032F |
6.1.4 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Radio Frequency, 2022 - 2032F |
6.1.5 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Iontophoresis, 2022 - 2032F |
6.1.6 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Microporation, 2022 - 2032F |
6.1.7 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Thermal, 2022 - 2032F |
6.1.8 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Mechanical arrays, 2022 - 2032F |
6.1.9 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Others, 2022 - 2032F |
6.1.10 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Others, 2022 - 2032F |
6.2 United States (US) Transdermal Drug Delivery Systems Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By CNS, 2022 - 2032F |
6.2.3 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Pain Management, 2022 - 2032F |
6.2.4 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Cardiovascular, 2022 - 2032F |
6.2.5 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Hormone, 2022 - 2032F |
6.2.6 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Immunological, 2022 - 2032F |
6.2.7 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Metabolic, 2022 - 2032F |
6.2.8 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Infection, 2022 - 2032F |
6.2.9 United States (US) Transdermal Drug Delivery Systems Market Revenues & Volume, By Infection, 2022 - 2032F |
7 United States (US) Transdermal Drug Delivery Systems Market Import-Export Trade Statistics |
7.1 United States (US) Transdermal Drug Delivery Systems Market Export to Major Countries |
7.2 United States (US) Transdermal Drug Delivery Systems Market Imports from Major Countries |
8 United States (US) Transdermal Drug Delivery Systems Market Key Performance Indicators |
8.1 Patient adherence rate to transdermal drug delivery systems |
8.2 Number of new product launches in the transdermal drug delivery systems market |
8.3 Research and development investment in enhancing transdermal drug delivery technologies |
9 United States (US) Transdermal Drug Delivery Systems Market - Opportunity Assessment |
9.1 United States (US) Transdermal Drug Delivery Systems Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 United States (US) Transdermal Drug Delivery Systems Market Opportunity Assessment, By Application, 2022 & 2032F |
10 United States (US) Transdermal Drug Delivery Systems Market - Competitive Landscape |
10.1 United States (US) Transdermal Drug Delivery Systems Market Revenue Share, By Companies, 2025 |
10.2 United States (US) Transdermal Drug Delivery Systems Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here